Translational Pharmaceutics®: Now With Drug Substance

15 years and 500 studies completed.

Reduce your development times and costs with Translational Pharmaceutics®.

Expertise spanning from candidate development to commercial manufacturing.

Our expertise in understanding dependencies between drug substance properties, formulation development, and clinical outcomes enables us to enhance efficiency.

By having both drug substance and drug product manufacturing activities under one organization, we can now deliver integrated chemistry, manufacturing, and controls (CMC) development activities for both preclinical and clinical studies in parallel, simplifying the supply chain and shortening the time from candidate selection to clinic by a further 2–4 months.

Key benefits of Translational Pharmaceutics®:

  • Timeline acceleration of >12 months
  • Significant reduction in R&D spend
  • Improved data for better decision making
  • Greater likelihood of success
  • Simplified supply chain
  • >500 studies completed & >200 scientific publications

Translational Pharmaceutics®: What our customers say

Get in touch
Humanity can't afford to wait, so neither can we.